Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
Abstract Background Sulfadoxine-pyrimethamine (SP), as a partner to artesunate as ACT is the treatment of choice for uncomplicated P.falciparum infections milwaukee mnm1-600 in the majority of India and SP-resistance has a potential to lead to ACT failure.In the lack of robust surveillance of therapeutic efficacy of SP, validate molecular markers o